Dr. Abass Alavi, a professor of radiology at the University of Pennsylvania, is the first nuclear medicine physician to receive the University of Bologna's prestigious laurea honoris causa. Alavi received the honorary doctorate in medicine and surgery for his contribution to the development of the radiotracer FDG.
Dr. Abass Alavi, a professor of radiology at the University of Pennsylvania, is the first nuclear medicine physician to receive the University of Bologna's prestigious laurea honoris causa. Alavi received the honorary doctorate in medicine and surgery for his contribution to the development of the radiotracer FDG.
"Many specialists trained by Abass are at present chairing important centers in all continents," said Dr. Stefano Fanti, chair of nuclear medicine at the University of Bologna, during the ceremony. "Abass Alavi represents the synthesis of the skills that every teacher should reach and express: the skill of scientific logic and the quality of teaching."
The announcement appeared in the October issue of the Journal of Nuclear Medicine.
Study with CT Data Suggests Women with PE Have More Than Triple the One-Year Mortality Rate than Men
April 3rd 2025After a multivariable assessment including age and comorbidities, women with pulmonary embolism (PE) had a 48 percent higher risk of one-year mortality than men with PE, according to a new study involving over 33,000 patients.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Predicting Diabetes on CT Scans: What New Research Reveals with Pancreatic Imaging Biomarkers
March 25th 2025Attenuation-based biomarkers on computed tomography (CT) scans demonstrated a 93 percent interclass correlation coefficient (ICC) agreement across three pancreatic segmentation algorithms for predicting diabetes, according to a study involving over 9,700 patients.
Can Photon-Counting CT be an Alternative to MRI for Assessing Liver Fat Fraction?
March 21st 2025Photon-counting CT fat fraction evaluation offered a maximum sensitivity of 81 percent for detecting steatosis and had a 91 percent ICC agreement with MRI proton density fat fraction assessment, according to new prospective research.